Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

13,303 total articles

Astera Labs director sells $4.38 million in stock under 10b5-1 plan

Astera Labs director sells $4.38 million in stock under 10b5-1 plan

Stefan A. Dyckerhoff, a director at Astera Labs Inc. (NASDAQ: ALAB), sold 24,998 shares of common stock on April 17 and April 20, 2026, under a Rule 10b5-1 trading arrangement adopted December 1, 2025. The disposals amounted to $4,376,257 at prices between $175.00 and $175.51 per share. The transactions occurred as ALAB shares have risen 223% over …

Dyne Therapeutics Director ForDyne Entity Sells $6.8M in Stock

Dyne Therapeutics Director ForDyne Entity Sells $6.8M in Stock

Dirk Kersten, through an entity he is affiliated with, recorded the sale of 337,248 shares of Dyne Therapeutics (NASDAQ:DYN) in two transactions on April 17 and April 20, 2026, generating roughly $6.82 million. The disposals were carried out indirectly by ForDyne B.V. under a Rule 10b5-1 trading plan adopted in November 2025. The filings also show …

Arteris Director Executes $1.99M in Stock Sales Under 10b5-1 Plan

Arteris Director Executes $1.99M in Stock Sales Under 10b5-1 Plan

Saiyed Atiq Raza, a director of Arteris, Inc. (NASDAQ: AIP), sold roughly $1.99 million in company shares across two trades on April 17 and April 20, 2026, under a 10b5-1 plan adopted November 7, 2025. The sales were executed via a revocable trust for which Mr. Raza serves as trustee. The disclosure comes as the stock trades near its 52-week high a…

Travelers EVP Disposes Nearly $2.0 Million in Company Stock

Travelers EVP Disposes Nearly $2.0 Million in Company Stock

Jeffrey P. Klenk, Executive Vice President and President of Bond & Specialty Insurance at Travelers Companies, sold 6,413.654 shares of common stock on April 20, 2026, generating $1,956,549 at $305.06 per share. The sale was disclosed in an SEC filing dated April 21, 2026. After the transaction, Klenk retains direct ownership of 6,075.303 shares. T…

XCF Global Insider Sells $656,151 in Class A Shares; Company Reports Progress on Reno Facility and Partnerships

XCF Global Insider Sells $656,151 in Class A Shares; Company Reports Progress on Reno Facility and Partnerships

Randy Soule, a ten percent stakeholder in XCF Global, Inc. (SAFX), sold 1,261,830 shares of Class A common stock on March 12, 2026, for a total of $656,151 at $0.52 per share. The sale was disclosed in an SEC Form 4 filing and follows steep recent declines in the company’s share price. Separately, XCF Global filed its first Form 10-K and reported o…

Saba Capital Reduces Stake in BlackRock ECAT with $201,492 Sale

Saba Capital Reduces Stake in BlackRock ECAT with $201,492 Sale

Saba Capital Management, L.P., an indirect holder representing a reported ten percent interest in BlackRock ESG Capital Allocation Term Trust (NASDAQ: ECAT), sold 13,782 shares on April 20, 2026 at $14.62 per share, generating roughly $201,492. After the transaction the firm retains 21,514,400 shares. The trust trades at $14.54, has returned 27% ov…